Pacira BioSciences, Inc.
Ownership
Ownership Structure
Who owns Pacira BioSciences, Inc. (PCRX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 90.8% of the shares are freely tradable; institutional investors hold 115.4%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 16.90 | 6,735,343 | -4.7 | 03/31/2026 |
| Doma Perpetual Capital Management LLC | 6.97 | 2,777,794 | +0.0 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 6.27 | 2,501,286 | +0.0 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 5.28 | 2,103,245 | +2.1 | 06/30/2026 |
| D. E. Shaw & Co LP | 4.89 | 1,950,332 | -1.6 | 06/30/2026 |
| State Street Corp | 4.82 | 1,919,610 | +1.9 | 03/31/2026 |
| Renaissance Technologies Corp | 4.58 | 1,825,501 | -3.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.48 | 1,784,049 | +0.0 | 03/31/2026 |
| The Goldman Sachs Group Inc | 3.94 | 1,569,916 | +20.7 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 6.01 | 2,394,216 | -0.4 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Slonin Jonathan | Chief Medical Officer | 216,384 | 5,301,399 $ | Aug 17, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Slonin Jonathan | Chief Medical Officer | Sell | 3,040 | 23.23 | 70,619 |
| Apr 23, 2026 | Shawn Cross | CFO | Sell | 12,941 | 25.16 | 325,596 |
| Apr 22, 2026 | Shawn Cross | CFO | Sell | 1,500 | 25.01 | 37,515 |
| Apr 21, 2026 | Shawn Cross | CFO | Sell | 2,845 | 25.01 | 71,153 |
| Apr 20, 2026 | Shawn Cross | CFO | Sell | 7,714 | 25.14 | 193,930 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.